Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind placebo-controlled study of ARA 290 for neuropathic symptoms in type 2 diabetes
NL-OMON21147Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Trial of cibinetide, sponsored by Leiden University Medical Center. Planned start Mar 2013; status: not yet recruiting.
02
Drugs
cibinetide
Beyond the preview
Go deeper on NL-OMON21147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21147.